| PRECISION BIOSCIENCES |
| USA |
| Gesundheit |
| US74019P2074 / A400AS |
| PBS0 (Frankfurt) / DTIL (NASDAQ) |
| FRA:PBS0, ETR:PBS0, PBS0:GR, NASDAQ:DTIL |
| - |
| https://precisionbioscien.. |
|
Precision BioSciences Inc. is a clinical-stage biotechnology company specializing in in vivo gene editing therapies for genetic and infectious diseases with high unmet medical needs. It leverages its proprietary ARCUS genome editing platform, derived..
>Volltext.. |
| 154.66 Mio. EUR |
| 91.47 Mio. EUR |
| 38.82 Mio. EUR |
| -31.37 Mio. EUR |
| -38.31 Mio. EUR |
| -3.19 EUR |
| 24.51 Mio. EUR |
| 85.58 Mio. EUR |
| - |
| 13.05 |
| -17.47% |
| -89.46% |
| - |
| - |
| - |
| - |
| PRECISION BIOSCIENCES, PRECISION BIO |
| 20.05.26 |
|